87 related articles for article (PubMed ID: 25014371)
1. Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes.
Ringhieri P; Iannitti R; Nardon C; Palumbo R; Fregona D; Morelli G; Accardo A
Int J Pharm; 2014 Oct; 473(1-2):194-202. PubMed ID: 25014371
[TBL] [Abstract][Full Text] [Related]
2. Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent.
Accardo A; Salsano G; Morisco A; Aurilio M; Parisi A; Maione F; Cicala C; Tesauro D; Aloj L; De Rosa G; Morelli G
Int J Nanomedicine; 2012; 7():2007-17. PubMed ID: 22619538
[TBL] [Abstract][Full Text] [Related]
3. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation.
Ashok B; Arleth L; Hjelm RP; Rubinstein I; Onyüksel H
J Pharm Sci; 2004 Oct; 93(10):2476-87. PubMed ID: 15349957
[TBL] [Abstract][Full Text] [Related]
4. Multifunctionalized gold nanoparticles with peptides targeted to gastrin-releasing peptide receptor of a tumor cell line.
Hosta-Rigau L; Olmedo I; Arbiol J; Cruz LJ; Kogan MJ; Albericio F
Bioconjug Chem; 2010 Jun; 21(6):1070-8. PubMed ID: 20476781
[TBL] [Abstract][Full Text] [Related]
5. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R
Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
[TBL] [Abstract][Full Text] [Related]
6. Gold nanorods-bombesin conjugate as a potential targeted imaging agent for detection of breast cancer.
Heidari Z; Sariri R; Salouti M
J Photochem Photobiol B; 2014 Jan; 130():40-6. PubMed ID: 24300991
[TBL] [Abstract][Full Text] [Related]
7. Easy formulation of liposomal doxorubicin modified with a bombesin peptide analogue for selective targeting of GRP receptors overexpressed by cancer cells.
Accardo A; Mannucci S; Nicolato E; Vurro F; Diaferia C; Bontempi P; Marzola P; Morelli G
Drug Deliv Transl Res; 2019 Feb; 9(1):215-226. PubMed ID: 30569349
[TBL] [Abstract][Full Text] [Related]
8. Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancer chemotherapy.
Kouodom MN; Boscutti G; Celegato M; Crisma M; Sitran S; Aldinucci D; Formaggio F; Ronconi L; Fregona D
J Inorg Biochem; 2012 Dec; 117():248-60. PubMed ID: 22877925
[TBL] [Abstract][Full Text] [Related]
9. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid Micelles for Peptide Drug Delivery.
Esparza K; Jayawardena D; Onyuksel H
Methods Mol Biol; 2019; 2000():43-57. PubMed ID: 31148007
[TBL] [Abstract][Full Text] [Related]
11. Structure and dynamics of highly PEG-ylated sterically stabilized micelles in aqueous media.
Vuković L; Khatib FA; Drake SP; Madriaga A; Brandenburg KS; Král P; Onyuksel H
J Am Chem Soc; 2011 Aug; 133(34):13481-8. PubMed ID: 21780810
[TBL] [Abstract][Full Text] [Related]
12. Effects of peptide molecular mass and PEG chain length on the vasoreactivity of VIP and PACAP(1-38) in pegylated phospholipid micelles.
Ashok B; Rubinstein I; Tsueshita T; Onyüksel H
Peptides; 2004 Aug; 25(8):1253-8. PubMed ID: 15350692
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
Tong SW; Xiang B; Dong DW; Qi XR
Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
[TBL] [Abstract][Full Text] [Related]
14. Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs.
Krishnadas A; Rubinstein I; Onyüksel H
Pharm Res; 2003 Feb; 20(2):297-302. PubMed ID: 12636171
[TBL] [Abstract][Full Text] [Related]
15. The effect of DSPE-PEG
Zhang W; Wang Z; Wu C; Jin Y; Liu X; Wu Z; Liu J
Eur J Pharm Sci; 2018 Dec; 125():74-85. PubMed ID: 30236551
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs.
Sezgin Z; Yüksel N; Baykara T
Eur J Pharm Biopharm; 2006 Nov; 64(3):261-8. PubMed ID: 16884896
[TBL] [Abstract][Full Text] [Related]
17. Investigation of cancer cell lines for peptide receptor-targeted drug development.
Sun L; Luo J; Mackey LV; Morris LM; Franko-Tobin LG; LePage KT; Coy DH
J Drug Target; 2011 Sep; 19(8):719-30. PubMed ID: 21830941
[TBL] [Abstract][Full Text] [Related]
18. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).
Chandran T; Katragadda U; Teng Q; Tan C
Int J Pharm; 2010 Jun; 392(1-2):170-7. PubMed ID: 20363305
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]